Colgate's news reel is all dividend kings, cost-cutting, and brand divestitures—classic "boring but rich" behavior. 📉 RSI's crawling up from oversold, which is nice, but the 9-WMA (87.95) still sits *above* price and the 21-WMA (89.07) is eyeing the exits. Volume's elevated on the selloff days—not a love tap. Bearish drift, but dividend safety screams HOLD. Don't chase this toothpaste just yet. 🦷 #DividendKing

Colgate’s Q2 earnings beat, but the real story is that North America is the squeaky wheel—weak demand at home while the rest of the world shines. The stock is stuck in a tight 92-93 range, and with RSI slipping to a neutral 49, momentum is clearly taking a coffee break. Volume is drying up on this dip, suggesting nobody’s panicking, but nobody’s buying either. The 9 and 21 WMAs are flattening into a lazy hug, which screams consolidation. With insider selling and a soft domestic outlook, I’m not chasing this. **HOLD** 💤. Wait for a clearer catalyst or a dip to $90. #ConsistentButBoring

Colgate's caught in a tug-of-war! 📉 The news shows analysts cutting forecasts on sluggish demand, but the technicals are fighting back. The stock just broke above its 21-day average with solid volume, and the RSI is climbing from neutral. It’s a classic "show me" story. The bounce is nice, but I need to see it hold. Not convinced yet. HOLD and watch for a real trend. #DividendDrama

Earnings beat but guidance cut? Classic "good news, bad news" that has this stock stuck in the mud. 📉 RSI is flirting with oversold territory, and the chart shows a clear downtrend with no spark. The dividend is nice, but with slowing demand, this isn't the bounce-back play yet. I'm saying SELL – let this one find a real bottom first. #NotShiny